NEW YORK, March 3, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQ: NMRA). Such investors are advised to contact Danielle Peyton […]
Tag: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Manhattan Associates, Inc. of Class Action Lawsuit and Upcoming Deadlines
NEW YORK, Feb. 27, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Manhattan Associates (“Manhattan Associates” or the “Company”) (NASDAQ: MANH). Such investors are advised to contact Danielle Peyton […]
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Lab USA, Inc.
NEW YORK, Feb. 26, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Rocket Lab USA, Inc (“Rocket Lab” or the “Company”) (NASDAQ: RKLB). Such investors are advised to contact Danielle […]
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Civitas Resources, Inc.
NEW YORK, Feb. 26, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Civitas Resources, Inc (“Civitas” or the “Company”) (NYSE: CIVI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Geron Corporation
NEW YORK, Feb. 26, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Geron Corporation (“Geron” or the “Company”) (NASDAQ: GERN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. […]
